Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 19, 2025Renal FailureOpen Access

Sirtuin 3 in diabetic kidney disease: mechanisms and pharmacotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

YCYinfeng ChenYWYing WangDYDongrong Yu

Discussion

Loading...

Member takes

Overview

Review reveals sirtuin 3’s impact on mitochondrial functions in diabetic kidney disease, suggesting pharmacotherapy potential.

Key Points

  • Sirtuin 3 delays progression of diabetic kidney disease by inhibiting oxidative stress and reducing inflammation.
  • Key mechanisms include regulating energy metabolism and modulating cell death, enhancing overall kidney function.
  • This review analyzes mitochondrial functions impacted by sirtuin 3, highlighting its potential as a therapeutic target for DKD.
  • Findings indicate a need for clinical validation of sirtuin 3 activators in renal diseases, emphasizing therapeutic prospects.

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/68af35d5cf1dd9ea359e9970https://doi.org/10.1080/0886022x.2025.2543927
View Full Paper
Ask AI
Bookmark
Share